Check out Vicky Bartlett discussing private equity's growing presence in cardiology w/ Robert Harrington on the theheartorg | Medscape podcast 👇, based on a recent study she and Michael Liu published in JACC Journals Link: medscape.com/viewarticle/10… Study: jacc.org/doi/10.1016/j.…

We are proud to announce the first patient enrollment today at Saint Luke's Mid America Heart Institute for the fourth and final clinical trial (FINALITY-HF) of the larger MOONRAKER program on finerenone in heart failure. FINEARTS-HF, the first in the finerenone program,

🔴The Echo Right Heart catheterization ✅Echocardiographic correlate of Right Heart Pressures & PCWP ✅Estimating chamber pressures via echocardiographic doppler parameters #CardioEd #Cardiology #FOAMed #meded #MedEd #Cardiology #CardioTwitter #cardiotwitter #cardiotwiteros

The Proceedings of the7th World Symposium on Pulmonary Hypertension #PH are available on the ERJ website Pulmotension Société de Pneumologie de Langue Française (SPLF) HTaPFrance InsermU999 erj.ersjournals.com/cc/the-seventh…

Mechanistic Differences between Torsemide and Furosemide Prospective data debunks classic teachings 🔵No meaningful PK/PD advantages for T 🔵Kidney bioavailability less w T 🔵Ratio T:F was 4:1 (not 2:1!) 🔵T w ⬆️neurohormonal activ & kidney dysfunction journals.lww.com/jasn/abstract/…

#FINEARTSHF HFmrEF/HFpEF population Finerenone vs placebo Reduced primary endpoint (CVD / HF events) Looking forward to ongoing subsequent trials and analyses.

#FineArtsHF RCT 7463 pts with HF and EF of at least 40% (Mean LVEF 53%) #Fineronone, a nsMRA: ⬇️ the primary composite CV death & HF events by 16%, largely driven ⬇️ HF events Results consistent across subgroups Lower hypoK Higher hyperK #ESCCongress

🔥 A new therapeutic era in #HFpEF #FINEARTSHF with definitive evidence supporting the role of the non-steroidal MRA finerenone at #ESCCongress Now in NEJM nejm.org/doi/full/10.10…

FINE-ARTS #ESC2024 results very exciting. We really do have options for pts with HFpEF now, incredible Notable this was presented in Europe though. As a US provider, I’m tired of limiting my enthusiasm by a “How are we going to get this paid for” feeling Thoughts? Am I wrong?

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: NEJM 🥸 Finaarts-HF: In patients with mildly reduced EF or preserved EF, finerenone resulted in lower MACE (HF + CV Death) vs. placebo 😱very cool #ESCCongress #ESCCongress2024 Summary 👇

We are excited to announce the 2024 Pulmonology Intensive for Advanced Practice Providers with PCE on Saturday, 11/23/24.🫁 Join us for a live, virtual conference designed for the educational needs of APPs! Register now to reserve your spot at heyor.ca/uoYzbd 🖥️

In this podcast episode, we interview Brian Rose, a cardiovascular PA, about the intersection of cardiology and pulmonology in managing patients with breathlessness.🫀 heyor.ca/hLdkDX @[Corinne Young](urn:li:person:OUer-x1Blo)<corinne-young-2bb8a824>

shame on UnitedHealthcare. Patient of mine with documented PAD,worsening dyspnea. Normal stress test and moderate pulmonary HTN. Request for R/L heart Cath..........DENIED. Every healthcare provider that works for the insurance carriers should loose their license for denying pt care!!

Friends, colleagues, PH patients, and anyone interested in a fun event, please join us for the first NC PH walk!! UNC Health Duke Health The Pulmonary Hypertension Association Duke Heart Team PHenomenal Hope Sudarshan Rajagopal UNC Department of Medicine UNC Pulmonary and Critical Care Fellowship Duke Pulmonary Allergy and Critical Care Duke Pulm Fellows

The CAPP National Conference is coming up on October 17-19th! Join fellow Cardiology APPs and advance your practice with valuable #education and #networking opportunities. Use code SVM100 for free registration at CAPPLIVE.org! #CAPP #APPs #Cardiology #Vascular #SVM

Congrats to authors of AT HOME-HF pilot study of subQ furosemide in HF + worsening congestion - much needed randomized data to inform larger studies! SubQ Furosemide Enables HF Patients to Address Congestion at Home Duke Heart Duke Clinical Research Institute Michael Felker tctmd.com/news/subcutane…

Beta-Blockers for Secondary Prevention following #MI in Patients Without Reduced Ejection Fraction or #HeartFailure: An Updated Meta-Analysis Meta-analysis of 24 studies (290,349 patients) shows: 📍No significant mortality reduction in patients post-2010 with preserved EF (HR,

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more. nyti.ms/3BflkNl

Estimated treatment effects on CV outcomes, CKD progression and all-cause mortality with SGLT2i, GLP-1 RA, and ns-MRA, alone and in combination, when added to renin-angiotensin system blockade in patients with type 2 diabetes ca. 2024 from Circulation Brendon Neuen #Nephpearls 👉